2022 Q4 Form 10-Q Financial Statement

#000106299322021984 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $75.00K $75.00K $325.0K
YoY Change 0.0% -76.92% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $103.4K $121.3K $116.8K
YoY Change 17.63% 3.87% 22.24%
% of Gross Profit
Research & Development -$3.150K $1.070K $4.940K
YoY Change 12.5% -78.34% -7.32%
% of Gross Profit
Depreciation & Amortization $330.00 $330.00 $620.00
YoY Change -46.77% -46.77% -88.17%
% of Gross Profit
Operating Expenses $100.6K $143.9K $122.3K
YoY Change 17.33% 17.67% 15.29%
Operating Profit -$68.91K $188.5K
YoY Change -136.56%
Interest Expense $68.99K -$230.1K -$842.9K
YoY Change -348.43% -72.71% -200.81%
% of Operating Profit -447.15%
Other Income/Expense, Net -$16.05K -$229.6K -$440.00
YoY Change -2033.73% 52076.82% -320.0%
Pretax Income $20.00K -$298.5K -$654.9K
YoY Change -136.86% -54.42% -162.75%
Income Tax
% Of Pretax Income
Net Earnings $19.06K -$298.5K -$654.9K
YoY Change -132.16% -54.42% -162.75%
Net Earnings / Revenue 25.41% -397.99% -201.5%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share $0.00 -$10.76K
COMMON SHARES
Basic Shares Outstanding 60.86M shares 60.86M shares 60.86M shares
Diluted Shares Outstanding 60.86M shares 60.86M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.421M $840.8K $1.221M
YoY Change 22.89% -31.11% 255.1%
Cash & Equivalents $682.7K $840.8K $1.221M
Short-Term Investments $738.6K
Other Short-Term Assets $20.11K $37.14K $34.66K
YoY Change 9.35% 7.16% 3.15%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.441M $878.0K $1.255M
YoY Change 22.67% -30.06% 232.66%
LONG-TERM ASSETS
Property, Plant & Equipment $280.9K $281.2K $283.1K
YoY Change -0.55% -0.65% -4.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $669.6K $1.548M
YoY Change -56.74% -51.48%
Other Assets
YoY Change
Total Long-Term Assets $280.9K $950.8K $1.831M
YoY Change -84.42% -48.07% -47.47%
TOTAL ASSETS
Total Short-Term Assets $1.441M $878.0K $1.255M
Total Long-Term Assets $280.9K $950.8K $1.831M
Total Assets $1.722M $1.829M $3.086M
YoY Change -42.17% -40.74% -20.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.60K $34.87K $28.20K
YoY Change 140.0% 23.65% -68.74%
Accrued Expenses $146.7K $151.7K $246.9K
YoY Change -12.0% -38.55% -13.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $28.77K $66.77K
YoY Change -100.0% -56.91% -37.35%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.221M $1.359M $1.452M
YoY Change -12.95% -6.38% -7.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $81.25K $65.00K $65.00K
YoY Change 25.0% 0.0% 0.0%
Total Long-Term Liabilities $81.25K $65.00K $65.00K
YoY Change 25.0% 0.0% 35.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.221M $1.359M $1.452M
Total Long-Term Liabilities $81.25K $65.00K $65.00K
Total Liabilities $1.302M $1.424M $1.690M
YoY Change -11.26% -15.75% -9.2%
SHAREHOLDERS EQUITY
Retained Earnings -$6.351M -$6.370M
YoY Change 24.37%
Common Stock $60.86K $60.86K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 11.70K shares 11.70K shares
Shareholders Equity $250.2K $231.2K $1.396M
YoY Change
Total Liabilities & Shareholders Equity $1.722M $1.829M $3.086M
YoY Change -42.17% -40.74% -20.11%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $19.06K -$298.5K -$654.9K
YoY Change -132.16% -54.42% -162.75%
Depreciation, Depletion And Amortization $330.00 $330.00 $620.00
YoY Change -46.77% -46.77% -88.17%
Cash From Operating Activities -$124.3K -$45.34K -$95.36K
YoY Change 110.89% -52.45% 926.48%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $250.0K
YoY Change -100.0% 0.0%
Cash From Investing Activities $0.00 $0.00 $250.0K
YoY Change -100.0% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $35.53K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -33.77K 0.000 35.54K
YoY Change 575.4% -100.0%
NET CHANGE
Cash From Operating Activities -124.3K -45.34K -95.36K
Cash From Investing Activities 0.000 0.000 250.0K
Cash From Financing Activities -33.77K 0.000 35.54K
Net Change In Cash -158.1K -45.34K 190.2K
YoY Change 147.2% -123.84% -20.99%
FREE CASH FLOW
Cash From Operating Activities -$124.3K -$45.34K -$95.36K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
669624 usd
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1520684 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-654857 usd
us-gaap Net Income Loss
NetIncomeLoss
-512537 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1510322 usd
us-gaap Net Income Loss
NetIncomeLoss
-1263799 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-298490 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-654857 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60855579 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60855579 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60855579 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
11700 shares
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
500000 usd
CY2022Q3 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 usd
CY2021Q3 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 usd
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 usd
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
92685 usd
CY2022Q3 us-gaap Other Income
OtherIncome
494 usd
CY2021Q3 us-gaap Other Income
OtherIncome
-436 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60855579 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60855579 shares
us-gaap Gain Loss On Investments
GainLossOnInvestments
500000 usd
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
649557 usd
thmg Proceeds From Mineral Interest
ProceedsFromMineralInterest
0 usd
thmg Proceeds From Mineral Interest
ProceedsFromMineralInterest
500000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2011118 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1569581 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-851060 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
thmg Shares Issued For Settlement Of Option Exercise With Accrued Interest And Wages
SharesIssuedForSettlementOfOptionExerciseWithAccruedInterestAndWages
35466 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
0 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-230072 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-298490 usd
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60855579 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60855579 shares
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
92685 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-15000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-20000 usd
thmg Increase Decrease Accrued Interest Payable To Related Parties
IncreaseDecreaseAccruedInterestPayableToRelatedParties
-60479 usd
thmg Increase Decrease Accrued Interest Payable To Related Parties
IncreaseDecreaseAccruedInterestPayableToRelatedParties
-190 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
35534 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
39808 usd
thmg Shares Issued For Settlement Of Option Exercise With Accrued Interest And Wages
SharesIssuedForSettlementOfOptionExerciseWithAccruedInterestAndWages
0 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000 usd
CY2021Q3 thmg Additional Common Shares To Settle Advanced Funds Accrued Wages And Accrued Interest
AdditionalCommonSharesToSettleAdvancedFundsAccruedWagesAndAccruedInterest
354648 shares
CY2021Q3 thmg Value Of Additional Common Shares To Settle Advanced Funds Accrued Wages And Accrued Interest
ValueOfAdditionalCommonSharesToSettleAdvancedFundsAccruedWagesAndAccruedInterest
35466 usd
CY2021Q3 thmg Options Exercised For Cash
OptionsExercisedForCash
355352 shares
CY2021Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
35534 usd
thmg Amount Of Compensation Paid To Board Of Directors
AmountOfCompensationPaidToBoardOfDirectors
16550 usd
CY2022Q3 thmg Amount Of Compensation Paid To Board Of Directors
AmountOfCompensationPaidToBoardOfDirectors
2900 usd
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
710000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.1
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000 usd
CY2021Q3 thmg Options Exercised For Cash
OptionsExercisedForCash
355352 shares
CY2021Q3 thmg Additional Common Shares To Settle Advanced Funds Accrued Wages And Accrued Interest
AdditionalCommonSharesToSettleAdvancedFundsAccruedWagesAndAccruedInterest
354648 shares
CY2021Q3 thmg Value Of Additional Common Shares To Settle Advanced Funds Accrued Wages And Accrued Interest
ValueOfAdditionalCommonSharesToSettleAdvancedFundsAccruedWagesAndAccruedInterest
35466 usd
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
710000 shares

Files In Submission

Name View Source Status
0001062993-22-021984-index-headers.html Edgar Link pending
0001062993-22-021984-index.html Edgar Link pending
0001062993-22-021984.txt Edgar Link pending
0001062993-22-021984-xbrl.zip Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10qxz001.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10qxz002.jpg Edgar Link pending
form10qxz003.jpg Edgar Link pending
form10qxz004.jpg Edgar Link pending
form10qxz005.jpg Edgar Link pending
form10qxz006.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thmg-20220930.xsd Edgar Link pending
thmg-20220930_cal.xml Edgar Link unprocessable
thmg-20220930_pre.xml Edgar Link unprocessable
thmg-20220930_lab.xml Edgar Link unprocessable
thmg-20220930_def.xml Edgar Link unprocessable
form10q_htm.xml Edgar Link completed